Bausch + Lomb Corporation Stock: price and insider trades · Canada

Every trade that managers of Bausch + Lomb Corporation disclose to SEDI is tracked on this page. The company sits in the Health Care sector. Over the twelve months to 18 October 2026, the company's managers filed 42 filings, from 15 insiders.

All open-market trades in the period are sales: 18 sales worth €551k, by 1 insider, with no purchase on record. At €116k, the sale published on 12 August 2026 by Munsch, Frederick John is the largest of the period (0.0022% of market cap).

Typically, a trade is published a median of 2 days after it takes place. The shorter that gap, the sooner other investors can see what insiders have done. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify.

For context, the typical company on the same exchange (median of 2,125 companies) published 12 filings over the same period, against 42 filings here. Over the whole record (from 2026), the tally stands at no purchases and 18 sales.

For comparison within the same sector, see the insider buying recorded at MAIA Biotechnology, Inc. and Cooper Companies, Inc. This summary is built from SEDI disclosures alone and does not predict where the share price will go.